ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,225
-0,06%
Bitcoin
66 579,25
0,58%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Actualités

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AZN
DateHeureSourceTitreSymboleSociété
12/06/202421h56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
12/06/202416h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
10/06/202409h30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
05/06/202410h27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202408h00RNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
04/06/202413h00PR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
03/06/202416h05RNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
03/06/202416h00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
03/06/202409h59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202408h00RNS Regulatory NewsAstraZeneca PLC Tagrisso plus chemo recommended for approval in EULSE:AZNAstrazeneca Plc
29/05/202409h54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
28/05/202408h00RNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
27/05/202408h49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
21/05/202413h18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202409h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202409h24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202411h27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202408h00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
08/05/202410h44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202408h46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202411h04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202408h00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
29/04/202410h13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202408h05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202414h00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202410h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
CAP
Capgemini
EU
EN
Bouygues
FTSE
UKX
FTSE 100
EU
RI
Pernod Ricard
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
NYSE
KO
Coca Cola
EU
BN
Danone
USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
NASDAQ
AAPL
Apple
EU
VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés